학술논문
AESOP: Phase 2 Open-Label Trial of Avasopasem Manganese (GC4419) for Reduction of Esophagitis in Patients Receiving Chemoradiotherapy for Nonmetastatic Lung Cancer
Document Type
Abstract
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:S165-S165
Subject
Language
ISSN
0360-3016